BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25524029)

  • 1. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
    Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
    Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25 preselective anti-HIV vectors for improved HIV gene therapy.
    Kalomoiris S; Lawson J; Chen RX; Bauer G; Nolta JA; Anderson JS
    Hum Gene Ther Methods; 2012 Dec; 23(6):366-75. PubMed ID: 23216020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
    Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP
    Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.
    Joseph A; Zheng JH; Chen K; Dutta M; Chen C; Stiegler G; Kunert R; Follenzi A; Goldstein H
    J Virol; 2010 Jul; 84(13):6645-53. PubMed ID: 20410262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.
    Ramsubir S; Nonaka T; Girbés CB; Carpentier S; Levade T; Medin JA
    Mol Genet Metab; 2008 Nov; 95(3):133-41. PubMed ID: 18805722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication.
    Davis BM; Humeau L; Dropulic B
    Mol Ther; 2004 Feb; 9(2):160-72. PubMed ID: 14759800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
    Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplantation in the context of HIV--how can we cure HIV infection?
    Bauer G; Anderson JS
    Expert Rev Clin Immunol; 2014 Jan; 10(1):107-16. PubMed ID: 24308835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo.
    Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS
    J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.
    Imren S; Fabry ME; Westerman KA; Pawliuk R; Tang P; Rosten PM; Nagel RL; Leboulch P; Eaves CJ; Humphries RK
    J Clin Invest; 2004 Oct; 114(7):953-62. PubMed ID: 15467834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.
    Dimitrova DI; Yang X; Reichenbach NL; Karakasidis S; Sutton RE; Henderson EE; Rogers TJ; Suhadolnik RJ
    J Interferon Cytokine Res; 2005 Jun; 25(6):345-60. PubMed ID: 15957958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Engraftment of Lentiviral Vector-Transduced Human CD34+ Cells into Humanized Mice.
    Kim YS; Wielgosz M; Ryu B
    Methods Mol Biol; 2019; 2005():91-100. PubMed ID: 31175648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.
    Urbinati F; Wherley J; Geiger S; Fernandez BC; Kaufman ML; Cooper A; Romero Z; Marchioni F; Reeves L; Read E; Nowicki B; Grassman E; Viswanathan S; Wang X; Hollis RP; Kohn DB
    Cytotherapy; 2017 Sep; 19(9):1096-1112. PubMed ID: 28733131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration.
    Kurre P; Anandakumar P; Harkey MA; Thomasson B; Kiem HP
    Mol Ther; 2004 Jun; 9(6):914-22. PubMed ID: 15194058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.
    Younan PM; Peterson CW; Polacino P; Kowalski JP; Obenza W; Miller HW; Milless BP; Gafken P; DeRosa SC; Hu SL; Kiem HP
    Mol Ther; 2015 May; 23(5):943-951. PubMed ID: 25648264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.